Answers are grounded in this paper and cite their sources.
Dihydropyrimidinase deficiency is a rare autosomal recessive disorder of the pyrimidine degradation pathway, with fewer than 40 patients published. Clinical findings are variable and some patients may remain asymptomatic. Global developmental delay and increased susceptibility to 5-fluorouracil are commonly reported. Here we present atrioventricular septal defect as a novel feature in dihydropyrimidinase deficiency.
No takes yet. Share an insight, caveat, or question.
Erdal et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: